Skip to main content
BNGO
NASDAQ Industrial Applications And Services

Bionano Genomics Reports Widened Q1 Loss, Reiterates Going Concern Warning Amid Cash Burn

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.3
Mkt Cap
$13.865M
52W Low
$1.06
52W High
$5.5
52W Position info
23% above low
Off High info
76% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BNGO sits 23% above its 52-week low of $1.06.

Summary

Bionano Genomics reported a significantly increased net loss for Q1 2026 and reiterated its going concern warning, citing substantial doubt about its ability to continue operations without additional funding. The company faces a high cash burn and a maturing debt obligation, despite recent ATM sales and a new shelf registration.


Key Events · Earnings and Guidance · BNGO

  • Reiterates Going Concern Warning

    Management explicitly states 'substantial doubt about the Company's ability to continue as a going concern' within twelve months due to recurring losses and negative cash flows.

  • Net Loss Widens Significantly

    Q1 2026 net loss increased to $8.3 million, a 168% increase compared to a $3.1 million net loss in Q1 2025.

  • Increased Cash Burn

    Cash used in operating activities rose to $5.7 million in Q1 2026, up from $2.8 million in Q1 2025, further straining liquidity.

  • Limited Cash Runway

    As of March 31, 2026, the company had $3.4 million in cash and cash equivalents and $11.0 million in short-term investments, providing a short runway given the current burn rate.


Analysis · BNGO · Industrial Applications And Services

Bionano Genomics' Q1 2026 results highlight severe liquidity challenges, with the company explicitly stating 'substantial doubt about its ability to continue as a going concern' within the next twelve months. The net loss significantly widened to $8.3 million, and cash used in operations increased to $5.7 million, further depleting its limited cash reserves. While a new $400 million shelf registration was filed, its immediate utility is constrained by the company's low market capitalization, limiting the amount of capital that can be raised. The upcoming maturity of $10.3 million in convertible debentures adds immediate financial pressure, necessitating urgent capital raises to avoid potential bankruptcy.

At the time of this filing, BNGO was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.9M. The 52-week trading range was $1.06 to $5.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BNGO - Latest Insights

BNGO
Jun 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $1.15 info
Change: $0 (0%) info
Market Cap: $13.311M info
BNGO
Jun 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.0188 (-2%) info
Market Cap: $13.311M info
BNGO
Jun 05, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.020 (-2%) info
Market Cap: $13.311M info
BNGO
Jun 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.15 info
Change: -$0.020 (-2%) info
Market Cap: $13.311M info
BNGO
May 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $1.27
Real-time Price: $1.15 info
Change: -$0.120 (-9%) info
Market Cap: $13.311M info